Compare ESLA & AIOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESLA | AIOK |
|---|---|---|
| Founded | 2021 | 2025 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 18.1M |
| IPO Year | 2021 | 2025 |
| Metric | ESLA | AIOK |
|---|---|---|
| Price | $0.44 | $11.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.9M | ★ 6.6M |
| Earning Date | 11-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $3.90 |
| 52 Week High | $3.01 | $31.09 |
| Indicator | ESLA | AIOK |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 54.64 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.51 | $31.09 |
| Average True Range (ATR) | 0.20 | 4.64 |
| MACD | -0.01 | 0.66 |
| Stochastic Oscillator | 19.56 | 22.80 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.